Meghmani Finechem Limited announced its expansion plans into Chlorotoluene and its value chain. The upcoming facility in its existing Chlor-Alkali Complex of Dahej will produce intermediates for manufacturing pharmaceutical and agro-chemical active ingredients, which are amongst the growing segments. The Chlorotoluene project is expected to be commissioned by Q4FY24 and would require a capex of 180 Cr which will be fully funded through internal accruals. Meghmani Finechem Ltd. expects annual revenue of INR 300 million from this project. The EBITDA margin is expected to be in range of 28% - 32% which is in line with company's overall margin guidance. Given the high asset turnover ratio of 1.6x, absolute EBIDTA will be high leading to ROCE of nearly 30%. This will boost up the 24% ROCE target by 2024. This is a first of its kind intermediate facility which will be backward integrated with Toluene Chlorination (Ring Chlorination) plant in India. This entails a new set of opportunities for value addition of chlorine for an entirely new vertical. Indian Chlorotoluenes and its value chain demand are fulfilled through imports and hence, this facility will cater to the requirement for domestic and export market. This will also contribute in "MAKE IN INDIA" initiative to become Atmanirbhar Bharat, launched by our visionary Honourable Prime Minister.